NTLA reports Thursday, Nov 5, 2026, before the open. After the last 4 reports the stock moved +2.5%, +2.3%, +6.4%, −22.7% the next day.
NTLA is expected to report on Thursday, Nov 5, 2026, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Aug 6, 2026 | -0.78 | -0.80 | +2.5% | +10.2% |
| May 11, 2026 | -0.90 | -0.81 | +2.3% | −3.0% |
| Feb 26, 2026 | -0.96 | -0.83 | +6.4% | +3.0% |
| Nov 6, 2025 | -0.98 | -0.92 | −22.7% | −29.6% |
| Aug 7, 2025 | -1.01 | -0.98 | +0.8% | −3.3% |
| May 8, 2025 | -1.27 | -1.10 | +13.6% | +8.1% |
| Feb 27, 2025 | -1.32 | -1.27 | +0.6% | −13.3% |
| Nov 7, 2024 | -1.37 | -1.34 | −0.4% | +0.3% |
Average move the next trading day over the last 8 reports: ±6.2% (6 of 8 up).
NTLA is in a downtrend, momentum firm. $12 is the level overhead; $11.74 the first support below.
NTLA at $11.86. Nearest resistance $12.00 (+1.2%). Nearest support $11.74 (−1.0%).
NTLA chart, levels and analysis · Latest analysis: Intellia Therapeutics (NTLA) stock analysis, October 28, 2026: Sharp bounce inside a weekly downtrend, evidence even · Earnings this week
NTLA is expected to report on Thursday, Nov 5, 2026, before the open.
NTLA reports before the open, US Eastern time.
After its report on Aug 6, 2026, NTLA moved +2.5% the next trading day.
Over the last 8 reports, NTLA moved 6.2% on average the next trading day, up 6 times out of 8.